Reset Mind Sciences

Reset Mind Sciences, a Western Australian company focused on psychedelics and a subsidiary of ASX-listed Little Green Pharma ("LGP"), has recently received approval from the Human Research Ethics Committee for a clinical trial investigating a psilocybin-assisted psychotherapy protocol for the treatment of patients with treatment-resistant major depressive disorder.